Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic Vaccination in Stage III/IV Melanoma
NCT00007969Phase 2Completed
- Sponsor
- QLT Inc.
- Start
- Oct 2000
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of verteporfin in melanoma, sponsored by QLT Inc.. Started Oct 2000; status: completed.
02
Drugs
verteporfin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00007969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00007969.